Cargando…

Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial

PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac a...

Descripción completa

Detalles Bibliográficos
Autores principales: Koskensalo, Kalle, Virtanen, Sami, Saunavaara, Jani, Parkkola, Riitta, Laitio, Ruut, Arola, Olli, Hynninen, Marja, Silvasti, Päivi, Nukarinen, Eija, Martola, Juha, Silvennoinen, Heli M., Tiainen, Marjaana, Roine, Risto O., Scheinin, Harry, Saraste, Antti, Maze, Mervyn, Vahlberg, Tero, Laitio, Timo T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859870/
https://www.ncbi.nlm.nih.gov/pubmed/36251060
http://dx.doi.org/10.1007/s00234-022-03063-z
_version_ 1784874456179539968
author Koskensalo, Kalle
Virtanen, Sami
Saunavaara, Jani
Parkkola, Riitta
Laitio, Ruut
Arola, Olli
Hynninen, Marja
Silvasti, Päivi
Nukarinen, Eija
Martola, Juha
Silvennoinen, Heli M.
Tiainen, Marjaana
Roine, Risto O.
Scheinin, Harry
Saraste, Antti
Maze, Mervyn
Vahlberg, Tero
Laitio, Timo T.
author_facet Koskensalo, Kalle
Virtanen, Sami
Saunavaara, Jani
Parkkola, Riitta
Laitio, Ruut
Arola, Olli
Hynninen, Marja
Silvasti, Päivi
Nukarinen, Eija
Martola, Juha
Silvennoinen, Heli M.
Tiainen, Marjaana
Roine, Risto O.
Scheinin, Harry
Saraste, Antti
Maze, Mervyn
Vahlberg, Tero
Laitio, Timo T.
author_sort Koskensalo, Kalle
collection PubMed
description PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac arrest (OHCA). METHODS: The predictive accuracy of DTI, 1H-MRS, and NSE along with motor score at 72 h and ES for the poor neurological outcome (modified Rankin Scale, mRS, 3 − 6) in 92 comatose OHCA patients at 6 months was assessed by area under the receiver operating characteristic curve (AUROC). Combined models of the variables were included as exploratory. RESULTS: The predictive accuracy of fractional anisotropy (FA) of DTI (AUROC 0.73, 95% CI 0.62–0.84), total N-acetyl aspartate/total creatine (tNAA/tCr) of 1H-MRS (0.78 (0.68 − 0.88)), or NSE at 72 h (0.85 (0.76 − 0.93)) was not significantly better than motor score at 72 h (0.88 (95% CI 0.80–0.96)). The addition of FA and tNAA/tCr to a combination of NSE, motor score, and ES provided a small but statistically significant improvement in predictive accuracy (AUROC 0.92 (0.85–0.98) vs 0.98 (0.96–1.00), p = 0.037). CONCLUSION: None of the variables (FA, tNAA/tCr, ES, NSE at 72 h, and motor score at 72 h) differed significantly in predicting poor outcomes in this patient group. Early-phase quantitative neuroimaging provided a statistically significant improvement for the predictive value when combined with ES and motor score with or without NSE. However, in clinical practice, the additional value is small, and considering the costs and challenges of imaging in this patient group, early-phase DTI/MRS cannot be recommended for routine use. TRIAL REGISTRATION: ClinicalTrials.gov NCT00879892, April 13, 2009. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00234-022-03063-z.
format Online
Article
Text
id pubmed-9859870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98598702023-01-22 Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial Koskensalo, Kalle Virtanen, Sami Saunavaara, Jani Parkkola, Riitta Laitio, Ruut Arola, Olli Hynninen, Marja Silvasti, Päivi Nukarinen, Eija Martola, Juha Silvennoinen, Heli M. Tiainen, Marjaana Roine, Risto O. Scheinin, Harry Saraste, Antti Maze, Mervyn Vahlberg, Tero Laitio, Timo T. Neuroradiology Functional Neuroradiology PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac arrest (OHCA). METHODS: The predictive accuracy of DTI, 1H-MRS, and NSE along with motor score at 72 h and ES for the poor neurological outcome (modified Rankin Scale, mRS, 3 − 6) in 92 comatose OHCA patients at 6 months was assessed by area under the receiver operating characteristic curve (AUROC). Combined models of the variables were included as exploratory. RESULTS: The predictive accuracy of fractional anisotropy (FA) of DTI (AUROC 0.73, 95% CI 0.62–0.84), total N-acetyl aspartate/total creatine (tNAA/tCr) of 1H-MRS (0.78 (0.68 − 0.88)), or NSE at 72 h (0.85 (0.76 − 0.93)) was not significantly better than motor score at 72 h (0.88 (95% CI 0.80–0.96)). The addition of FA and tNAA/tCr to a combination of NSE, motor score, and ES provided a small but statistically significant improvement in predictive accuracy (AUROC 0.92 (0.85–0.98) vs 0.98 (0.96–1.00), p = 0.037). CONCLUSION: None of the variables (FA, tNAA/tCr, ES, NSE at 72 h, and motor score at 72 h) differed significantly in predicting poor outcomes in this patient group. Early-phase quantitative neuroimaging provided a statistically significant improvement for the predictive value when combined with ES and motor score with or without NSE. However, in clinical practice, the additional value is small, and considering the costs and challenges of imaging in this patient group, early-phase DTI/MRS cannot be recommended for routine use. TRIAL REGISTRATION: ClinicalTrials.gov NCT00879892, April 13, 2009. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00234-022-03063-z. Springer Berlin Heidelberg 2022-10-17 2023 /pmc/articles/PMC9859870/ /pubmed/36251060 http://dx.doi.org/10.1007/s00234-022-03063-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Functional Neuroradiology
Koskensalo, Kalle
Virtanen, Sami
Saunavaara, Jani
Parkkola, Riitta
Laitio, Ruut
Arola, Olli
Hynninen, Marja
Silvasti, Päivi
Nukarinen, Eija
Martola, Juha
Silvennoinen, Heli M.
Tiainen, Marjaana
Roine, Risto O.
Scheinin, Harry
Saraste, Antti
Maze, Mervyn
Vahlberg, Tero
Laitio, Timo T.
Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title_full Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title_fullStr Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title_full_unstemmed Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title_short Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
title_sort comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the xehypotheca trial
topic Functional Neuroradiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859870/
https://www.ncbi.nlm.nih.gov/pubmed/36251060
http://dx.doi.org/10.1007/s00234-022-03063-z
work_keys_str_mv AT koskensalokalle comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT virtanensami comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT saunavaarajani comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT parkkolariitta comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT laitioruut comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT arolaolli comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT hynninenmarja comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT silvastipaivi comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT nukarineneija comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT martolajuha comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT silvennoinenhelim comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT tiainenmarjaana comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT roineristoo comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT scheininharry comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT sarasteantti comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT mazemervyn comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT vahlbergtero comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT laitiotimot comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial
AT comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial